K110438 is an FDA 510(k) clearance for the SENSILASE PAD-IQ. Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.
Submitted by Vasamed, Inc. (Stoughton, US). The FDA issued a Cleared decision on May 4, 2011 after a review of 78 days - a notably fast clearance cycle.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.
View all Vasamed, Inc. devices